T. Rowe Price Investment Management’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,767,034
| Closed | -$40.7M | – | 644 |
|
|
2024
Q1 | $40.7M | Sell |
2,767,034
-2,872,960
| -51% | -$42.3M | 0.02% | 426 |
|
|
2023
Q4 | $54.3M | Buy |
5,639,994
+148,042
| +3% | +$1.42M | 0.04% | 384 |
|
|
2023
Q3 | $25.6M | Buy |
5,491,952
+29,300
| +0.5% | +$137K | 0.02% | 456 |
|
|
2023
Q2 | $29.2M | Buy |
5,462,652
+2,549,247
| +88% | +$13.6M | 0.02% | 441 |
|
|
2023
Q1 | $20.9M | Buy |
2,913,405
+36,677
| +1% | +$263K | 0.02% | 467 |
|
|
2022
Q4 | $19.3M | Sell |
2,876,728
-5,281
| -0.2% | -$35.4K | 0.01% | 462 |
|
|
2022
Q3 | $9.97M | Buy |
+2,882,009
| New | +$9.97M | 0.01% | 498 |
|